Ferngrove Pharmaceuticals Australia Pty Ltd.

The proceeding concerned a dispute between Ferngrove Pharmaceuticals Australia Pty Ltd and the Commissioner of Taxation. Ferngrove sought to recover income tax paid under objection, arguing that it was entitled to a deduction for certain expenditure incurred in the 2015 and 2016 income years. The Commissioner disallowed the deductions, leading to the present litigation before the Federal Court of Australia.

The primary legal issue before the Court was whether the expenditure incurred by Ferngrove constituted a "loss or outgoings to the extent that they are incurred in gaining or producing the assessable income" within the meaning of section 8-1 of the *Income Tax Assessment Act 1997* (Cth). Specifically, the Court had to determine if the expenditure was sufficiently connected to Ferngrove's business operations and the derivation of its assessable income, or if it was of a capital or private nature.

Justice Debrett Lyons found that the expenditure was not deductible under section 8-1. The Court reasoned that the expenditure was not incurred in the course of carrying on Ferngrove's business, but rather in relation to the acquisition of a capital asset, namely shares in another company. The Court applied the principles established in cases such as *Sun Newspapers Ltd v Federal Commissioner of Taxation* and *Chłon v Federal Commissioner of Taxation*, distinguishing between expenditure that is part of the process of operating a business and expenditure that is for the purpose of establishing, or acquiring an interest in, a business or capital structure. The Court concluded that the expenditure was capital in nature and therefore not deductible.